Piper Jaffray & Co. reiterates an Overweight on ABIOMED, Inc. (Nasdaq: ABMD); raises price target from $10 to $12

Piper ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE